On behalf of the Canadian Arthritis Patient Alliance (CAPA), we welcomed the opportunity to provide feedback on the draft guidance for biosimilar biologic drugs. Ensuring that patient perspectives are included in the development of policies is essential to improving...
In 2014, the Arthritis Alliance of Canada (AAC), a former nationwide coalition of more than thirty-five groups including people living with arthritis, health care professionals, researchers, funding agencies, government, voluntary sector agencies and industry...
Nous tenons à remercier tous les participants au webinaire de l’ACA sur le crédit d’impôt pour personnes handicapées (CIPH) qui a été organisé par les représentants de l’Agence du revenu du Canada le samedi 24 octobre 2020. Les participants ont pu en apprendre davantage sur les critères d’admissibilité et sur la façon de faire une demande...
Bill C-17 amends the Food and Drugs Act, which hasn’t been substantially updated in over 50 years. It was introduced to the House of Commons by the Minister of Health in December 2013. The Bill has two main goals: Strengthen safety oversight of therapeutic products...
Pain is the hallmark symptom of the various forms of arthritis. We’ve been involved in advocating on issues relating to arthritis pain, such as the federal action plan on opioids and the Chronic Pain Research Network. Health Canada information about Opioids...
Français du Canada 
English